XPO1 and T-cell acute lymphoblastic leukemia: Using this technique, Neggers et al. introduced a C528S point mutation in the XPO1 gene of acute T-cell leukemia cells, confirming that the small molecular inhibitor selinexor could specifically target and block the function of the nuclear export protein receptor XPO1.